Similarly, in the PSMAfore study, median rPFS was also observed to be significantly shorter for patients with detected versus undetected alterations in key PC genes, such as the androgen receptor gene (AR) and TP53, suggesting a potential for prognostic significance (68). The gene discussed is AR; the disease is pachyonychia congenita.